Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dare Bioscience (DARE) Interest & Investment Income (2016 - 2025)

Dare Bioscience's Interest & Investment Income history spans 7 years, with the latest figure at $156621.0 for Q1 2025.

  • For Q1 2025, Interest & Investment Income rose 77.71% year-over-year to $156621.0; the TTM value through Mar 2025 reached $297754.0, up 84.79%, while the annual FY2016 figure was $86000.0, 760.0% up from the prior year.
  • Interest & Investment Income reached $156621.0 in Q1 2025 per DARE's latest filing, up from $88133.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $156621.0 in Q1 2025 to a low of $88133.0 in Q1 2024.